EE
Eric J Ende
Director

Eric J Ende insider trades: Avadel Pharmaceuticals (AVDL) stock purchases

Director, Avadel Pharmaceuticals Last trade Jan 13, 2025 44 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2019
5
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Eric reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jan 13, 2025AVDL↑ Buy$235K
May 18, 2023AVDL↑ Buy$181K
Nov 22, 2022AVDL↑ Buy$156K
Jun 1, 2022AVDL↑ Buy$78K
May 27, 2022AVDL↑ Buy$37K
Sep 17, 2020AVDL↑ Buy$98K
Aug 13, 2020AVDL↑ Buy$39K
Aug 12, 2020AVDL↑ Buy$116K
Dec 4, 2019AVDL↑ Buy$60K
Nov 15, 2019AVDL↑ Buy$50K
Aug 20, 2019MTNB↑ Buy$13K
Aug 19, 2019MTNB↑ Buy$14K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other AVDL insiders

Open-market trades in the last 12 months

About Eric J Ende's insider trades

Eric J Ende is a director at Avadel Pharmaceuticals (AVDL). Since Aug 19, 2019, Eric has reported 12 open-market purchases worth $1.1M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (26 filings), other transactions (4 filings), shares returned to the company (3 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AVDL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.